(Q48186791)

9 February 2018

title

Risk of dementia in elderly patients with the use of proton pump inhibitors (English)

1 reference

9 February 2018

0 references

0 references

Christian Brettschneider

7

1 reference

9 February 2018

Hans-Helmut König

8

Hans-Helmut König

1 reference

9 February 2018

11

Melanie Luppa

1 reference

9 February 2018

Steffi G. Riedel-Heller

12

Steffi G Riedel-Heller

1 reference

9 February 2018

Michael Pentzek

14

Michael Pentzek

1 reference

9 February 2018

Horst Bickel

16

Horst Bickel

1 reference

9 February 2018

Siegfried Weyerer

10

Siegfried Weyerer

1 reference

9 February 2018

Martin Scherer

20

Martin Scherer

1 reference

9 February 2018

Birgitt Wiese

3

Birgitt Wiese

1 reference

9 February 2018

Frank Jessen

18

Frank Jessen

1 reference

9 February 2018

author name string

Britta Haenisch

1

1 reference

9 February 2018

Klaus von Holt

2

1 reference

9 February 2018

Jana Prokein

4

1 reference

9 February 2018

Carolin Lange

5

1 reference

9 February 2018

Annette Ernst

6

1 reference

9 February 2018

Jochen Werle

9

1 reference

9 February 2018

Angela Fuchs

13

1 reference

9 February 2018

Dagmar Weeg

15

1 reference

9 February 2018

Karl Broich

17

1 reference

9 February 2018

Wolfgang Maier

19

1 reference

9 February 2018

publication date

24 October 2014

1 reference

9 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

9 February 2018

volume

265

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

419-428

1 reference

9 February 2018

Prevalence and incidence of dementia in Germany--a study based on data from the public sick funds in 2002

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Epidemiology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Marked increase in proton pump inhibitors use in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Overprescribing proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Central nervous system side effects after proton pump inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

The proton-pump inhibitor lansoprazole enhances amyloid beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Cognitive function in an elderly population: interaction between vitamin B12 status, depression, and apolipoprotein E ε4: the Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Endolysosomal proteolysis and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Proton pump inhibitors: predisposers to Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Genome-wide association studies in Alzheimer's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Prediction of dementia in primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Polypharmacy in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Vitamin B12, folic acid, and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Vitamin B₁₂ status, cognitive decline and dementia: a systematic review of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Vitamin B12 deficiency in Australian residential aged care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0554-0

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

1 reference

12 December 2020

Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease

1 reference

12 December 2020

Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry

1 reference

12 December 2020

Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.

1 reference

12 December 2020

The worldwide economic impact of dementia 2010.

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00406-014-0554-0

Identifiers

DOI

1 reference

9 February 2018

release_4i64bwlhfnhepnkmenbhuk5tae

Fatcat ID

0 references

1 reference

9 February 2018